FDA's Confidential Information Protections Draw Questions From Congress
Executive Summary
House Energy & Commerce Committee leaders ask what additional steps agency has taken to safeguard trade secrets in wake of insider trading charges against former FDA official.
You may also be interested in...
Insider Trading: Pharma Employees Increasingly In SEC Crosshairs
In past month, three individuals in biopharma space have been charged with insider trading despite efforts by companies and associations to protect confidential information; past sentencing suggests length of jail time former FDA official Gordon Johnston is likely to face.
Insider Trading: Pharma Employees Increasingly In SEC Crosshairs
In past month, three individuals in biopharma space have been charged with insider trading despite efforts by companies and associations to protect confidential information; past sentencing suggests length of jail time former FDA official Gordon Johnston is likely to face.
Insider Trading By Ex-FDA Official Puts Spotlight On Current Agency Practices
After Office of Generic Drugs Deputy Director Gordon Johnston left FDA, he joined GPhA and 'tricked' a former colleague into sharing info on generic Lovenox on behalf of a hedge fund he was secretly working for, SEC says.